Picture of Inno-Gene SA logo

IGN Inno-Gene SA Income Statement

0.000.00%
pl flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual income statement for Inno-Gene SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSPRESSPRESS
Standards:
PAS
PAS
PAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1.364.6829.916.31.13
Cost of Revenue
Gross Profit1.233.2522.4120.443
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses1.613.221.216.33.43
Operating Profit-0.2551.488.66-0.041-2.3
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-0.2721.668.520.786-1.19
Provision for Income Taxes
Net Income After Taxes-0.2851.456.140.33-1.46
Minority Interest
Net Income Before Extraordinary Items
Net Income-0.1651.576.140.33-1.46
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-0.1651.576.140.33-1.46
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.0350.2761.080.058-0.256
Dividends per Share